EARLIER IDENTIFICATION AND EARLY INTERVENTION FOR CHILDREN WHO ARE DEAF OR HARD OF HEARING
With
Professor Greg Leigh AO, Director
NextSense Institute, Australia &
Conjoint Professor, Macquarie School of Education
Macquarie University, Sydney
RESEARCHER PROFILE
Filmed in Sydney, Australia | June 2025
As Director of NextSense Institute, Professor Leigh is responsible for leading the not-for-profit organisation’s world-class research and education programs and facilities.
Professor Leigh held a variety of positions in the education of children who are deaf or hard of hearing before entering academia. He holds a degree in Special Education from Griffith University, a Master of Science (Speech and Hearing) from Washington University and a PhD in Special Education from Monash University. In 2001, he was made a Fellow of the Australian College of Educators and in 2014, he was invested as an Officer in the Order of Australia (AO) for distinguished services to the deaf and hard of hearing community.
He is a member of the Editorial Board of The Journal of Deaf Studies and Deaf Education and has researched widely on issues related to the early development and education of children who are deaf or hard of hearing.
A former National President of the Education Commission for the World Congress of the World Federation of the Deaf, Professor Leigh has also Chaired the International Steering Committees of both the Asia-Pacific Congress on Deafness (APCD) and the International Congress on Education of the Deaf (ICED).
He has served on several Australian Government consultative committees, including the New South Wales Ministerial Standing Committee on Hearing, the National Neonatal Hearing Screening Working Party, and the Key Scientists Committee of the Hearing Cooperative Research Centre.
For the last 19 years, Professor Leigh has chaired the Australasian Newborn Hearing Screening Committee.
In his spare time, Professor Leigh is an active member/supporter of the Sydney Swans Football Club, and he and his wife enjoy symphonic music. He is also actively involved in the work of the St Vincent de Paul Society as a volunteer for the Vinnie’s Van program.
Source: Supplied
-
Pancreatic and lung cancers driven by mutations in the cancer gene KRAS
Dr Mara Zeissig is a recently appointed Lab Head within the Tumour Inflammation and Immunotherapy Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Her research focuses on studying immune evasion mechanisms in lung and pancreatic cancers to identify novel ways to increase response to immunotherapy. Her expertise is in genetically engineered mouse models of lung cancer, CRISPR-Cas9 screening technologies and T cell based immunotherapies (e.g Checkpoint inhibitors). -
Nuclear medicine & theranostics for molecular imaging & targeted therapy
Dr Aviral Singh is a globally renowned Nuclear Medicine Physician with special interest in Theranostics.
Dr Singh is based in Perth, Western Australia since 2024 and serves as the Clinical Head of Theranostics and Nuclear Medicine at GenesisCare Australia. He is also a Consultant Nuclear Medicine Physician at Fiona Stanley and Royal Perth Hospitals, in addition to pursuing national and international consulting physician roles as Director at Infinity Theranostics.
-
Hormone receptor positive breast cancer and therapy resistance
Prof Elgene Lim is a medical oncologist at St Vincent’s Hospital and Head of the Connie Johnson Breast Cancer Research Lab at the Garvan Institute. Following his PhD at the Walter & Eliza Hall Institute where he identified the aberrant cells in carriers of the BRCA1 mutant gene, a hereditary breast cancer syndrome as the culprit cells giving rise to breast cancer, he furthered his research and clinical training at the Dana-Farber Cancer Institute and Harvard Medical School. He was awarded the National Breast Cancer Foundation Practitioner Fellowship in 2014 and returned from Boston to Australia. In 2017, he was awarded the inaugural National Breast Cancer Foundation Endowed Chair, and subsequently appointed the Principal Cancer Theme Lead at UNSW.
